Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Careteq Ltd. ( (AU:CTQ) ).
Careteq Limited has issued 38,632,636 fully paid ordinary shares at $0.005 per share, expanding its share capital via a placement conducted without a disclosure document under the Corporations Act. The company confirmed it is compliant with its financial reporting and continuous disclosure obligations and stated there is no excluded information requiring disclosure, signalling regulatory adherence around the new equity issue.
The share issuance, authorised by the board, provides additional capital at a low issue price that may support Careteq’s ongoing healthtech operations and growth initiatives in medication management. While the announcement does not specify the intended use of funds, the placement slightly dilutes existing shareholders but underlines the company’s continued access to equity markets and its commitment to meeting statutory reporting standards.
The most recent analyst rating on (AU:CTQ) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on Careteq Ltd. stock, see the AU:CTQ Stock Forecast page.
More about Careteq Ltd.
Careteq Limited is an Australian healthtech company specialising in innovative medication management solutions for the aged care and home care sectors. Through its Embedded Health Solutions platform it delivers Residential Medication Management Reviews, while its HMR Referrals platform streamlines Home Medicines Reviews to improve healthcare outcomes.
Average Trading Volume: 714,052
Technical Sentiment Signal: Sell
For an in-depth examination of CTQ stock, go to TipRanks’ Overview page.

